| Unfit |  |  | Fit | ||
---|---|---|---|---|---|---|
 | No. (%) of MS | OR (95% CI) | P | No. (%) of MS | OR (95% CI) | P |
PA | Â | Â | Â | Â | Â | Â |
 Inactive | 14 (56.0) | 1 (reference) |  | 5 (14.3) | 1 (reference) |  |
 Active | 12 (34.3) | 0.68 (0.20–2.32) | 0.543 | 9 (10.1) | 0.28 (0.07–1.07) | 0.062 |
 | Inactive |  |  | Active |  |  |
 | No. (%) of MS | OR (95% CI) | P | No. (%) of MS | OR (95% CI) | P |
CRF | Â | Â | Â | Â | Â | Â |
 Unfit | 14 (56.0) | 1 (reference) |  | 12 (34.3) | 1 (reference) |  |
 Fit | 5 (14.3) | 0.18 (0.05–0.66) | 0.010 | 9 (10.1) | 0.55 (0.15–2.09) | 0.381 |